Exact Mass: 358.2018

Exact Mass Matches: 358.2018

Found 58 metabolites which its exact mass value is equals to given mass value 358.2018, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

NCIOpen2_008042

Estra-1,3,5(10),16-tetraen-3-ol benzoate

C25H26O2 (358.1933)


   

2-(3,7,11-Trimethyldodeca-2,6,10-trienylsulfanyl)benzoic acid

2-[(3,7,11-Trimethyldodeca-2,6,10-trien-1-yl)sulphanyl]benzoic acid

C22H30O2S (358.1966)


   

4,4'-Thiobis(6-tert-butyl-m-cresol)

2-tert-butyl-4-[(5-tert-butyl-4-hydroxy-2-methylphenyl)sulfanyl]-5-methylphenol

C22H30O2S (358.1966)


   
   

4,4-Thiobis(2-(tert-butyl)-5-methylphenol)

4,4-Thiobis(2-(tert-butyl)-5-methylphenol)

C22H30O2S (358.1966)


   
   
   

manadoperoxide I

manadoperoxide I

C18H30O7 (358.1991)


   

SCHEMBL352522

SCHEMBL352522

C18H30O7 (358.1991)


   

linalool-beta-D-glucopyranoside-2O-acetate

linalool-beta-D-glucopyranoside-2O-acetate

C18H30O7 (358.1991)


   

S-Farnesylthiosalicylic acid;Farnesyl Thiosalicylic Acid;FTS

S-Farnesylthiosalicylic acid;Farnesyl Thiosalicylic Acid;FTS

C22H30O2S (358.1966)


   

serylprolylarginine

serylprolylarginine

C14H26N6O5 (358.1965)


   
   
   

prolylserylarginine

prolylserylarginine

C14H26N6O5 (358.1965)


   
   
   
   
   

Salirasib

2-[[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl]thio]-benzoic acid

C22H30O2S (358.1966)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1902 - Ras Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors Salirasib is a Ras inhibitor that inhibits specifically both oncogenically activated Ras and growth factor receptor-mediated Ras activation, resulting in the inhibition of Ras-dependent tumor growth.

   

[5-(Cyclohexylamino)-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-1H-in dol-2-yl]boronic acid

[5-(Cyclohexylamino)-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-1H-in dol-2-yl]boronic acid

C19H27BN2O4 (358.2064)


   

TERT-BUTYL 5-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE

TERT-BUTYL 5-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE

C19H27BN2O4 (358.2064)


   
   

2,2-Thiobis(6-tert-butyl-p-cresol)

2,2-Thiobis(6-tert-butyl-p-cresol)

C22H30O2S (358.1966)


   
   

4-(trans-4-Propylcyclohexyl)-2,3-difluoro-4-ethoxy-1,1-biphenyl

4-(trans-4-Propylcyclohexyl)-2,3-difluoro-4-ethoxy-1,1-biphenyl

C23H28F2O (358.2108)


   

DI-TERT-BUTYL(2,6-DIMETHOXY-[1,1-BIPHENYL]-2-YL)PHOSPHINE

DI-TERT-BUTYL(2,6-DIMETHOXY-[1,1-BIPHENYL]-2-YL)PHOSPHINE

C22H31O2P (358.2062)


   

METHYL 1,4-DI-BOC-PIPERAZINE-2-ACETATE

METHYL 1,4-DI-BOC-PIPERAZINE-2-ACETATE

C17H30N2O6 (358.2104)


   

[1-[(2-methylpropan-2-yl)oxycarbonyl]-5-(piperidin-1-ylmethyl)indol-2-yl]boronic acid

[1-[(2-methylpropan-2-yl)oxycarbonyl]-5-(piperidin-1-ylmethyl)indol-2-yl]boronic acid

C19H27BN2O4 (358.2064)


   

1-N-BOC-3-METHYLINDAZOLE-5-BORONIC ACID PINACOL ESTER

1-N-BOC-3-METHYLINDAZOLE-5-BORONIC ACID PINACOL ESTER

C19H27BN2O4 (358.2064)


   

4,4-Thio-bis(2-methyl-6-tert-butylphenol)

4,4-Thio-bis(2-methyl-6-tert-butylphenol)

C22H30O2S (358.1966)


   

Hexaethylene glycol monophenyl ether

Hexaethylene glycol monophenyl ether

C18H30O7 (358.1991)


   

Cimetropium

Cimetropium

C21H28NO4+ (358.2018)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics

   

Estra-1,3,5(10),16-tetraen-3-ol benzoate

Estra-1,3,5(10),16-tetraen-3-ol benzoate

C25H26O2 (358.1933)


   

N2-[(Benzyloxy)carbonyl]-N1-[(3S)-1-cyanopyrrolidin-3-YL]-L-leucinamide

N2-[(Benzyloxy)carbonyl]-N1-[(3S)-1-cyanopyrrolidin-3-YL]-L-leucinamide

C19H26N4O3 (358.2005)


   

(S)-n-methyltetrahydropapaverine

(S)-n-methyltetrahydropapaverine

C21H28NO4+ (358.2018)


   

4-[[4-(2-Methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]-1-butanol

4-[[4-(2-Methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]-1-butanol

C18H26N6O2 (358.2117)


   

(1R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium

(1R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium

C21H28NO4+ (358.2018)


   

Trichosetin(1-)

Trichosetin(1-)

C21H28NO4- (358.2018)


An organic anion resulting from the deprotonation of the enol moiety of trichosetin.

   

(5S)-3-[(2E,6R,8E,10E,12E)-2,6-dimethyltetradeca-2,8,10,12-tetraenoyl]-5-(hydroxymethyl)pyrrolidine-2,4-dione

(5S)-3-[(2E,6R,8E,10E,12E)-2,6-dimethyltetradeca-2,8,10,12-tetraenoyl]-5-(hydroxymethyl)pyrrolidine-2,4-dione

C21H28NO4- (358.2018)


   
   

[4-[1-(1-Cyclopentyl-5-tetrazolyl)propyl]-1-piperazinyl]-(2-furanyl)methanone

[4-[1-(1-Cyclopentyl-5-tetrazolyl)propyl]-1-piperazinyl]-(2-furanyl)methanone

C18H26N6O2 (358.2117)


   
   
   
   
   
   

19-hydroxy-2,3-dinor-6-oxoprostaglandin F1alpha

19-hydroxy-2,3-dinor-6-oxoprostaglandin F1alpha

C18H30O7 (358.1991)


A prostanoid that is 2,3-dinor-6-oxo-prostaglandin F1alpha in which a hydrogen at position 19 is replaced by a hydroxy group.

   

(R)-laudanosine(1+)

(R)-laudanosine(1+)

C21H28NO4 (358.2018)


An organic cation that is the conjugate acid of (R)-laudanosine, obtained by protonation of the tertiary amino group; major species at pH 7.3.

   
   

(2r,3r,4r)-4-dodecyl-3-hydroxy-5-oxooxolane-2,3-dicarboxylic acid

(2r,3r,4r)-4-dodecyl-3-hydroxy-5-oxooxolane-2,3-dicarboxylic acid

C18H30O7 (358.1991)


   

2-[(1s,2s)-1-carboxy-2-methylbutyl]-5-hydroxy-5,7,7-trimethyl-9-oxo-5ah,6h-cyclopenta[g]isoquinolin-2-ium

2-[(1s,2s)-1-carboxy-2-methylbutyl]-5-hydroxy-5,7,7-trimethyl-9-oxo-5ah,6h-cyclopenta[g]isoquinolin-2-ium

[C21H28NO4]+ (358.2018)


   

4-dodecyl-3-hydroxy-5-oxooxolane-2,3-dicarboxylic acid

4-dodecyl-3-hydroxy-5-oxooxolane-2,3-dicarboxylic acid

C18H30O7 (358.1991)


   

(3s,4r,5s,6s,7r)-4,5,6,7-tetrahydroxy-3-(1-hydroxydecyl)-4,5,6,7-tetrahydro-3h-2-benzofuran-1-one

(3s,4r,5s,6s,7r)-4,5,6,7-tetrahydroxy-3-(1-hydroxydecyl)-4,5,6,7-tetrahydro-3h-2-benzofuran-1-one

C18H30O7 (358.1991)


   

methyl (2r,3s,3as,4s,5r,7s,7ar)-2-(acetyloxy)-3a,7-dihydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylate

methyl (2r,3s,3as,4s,5r,7s,7ar)-2-(acetyloxy)-3a,7-dihydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylate

C18H30O7 (358.1991)


   

(2r,3r,4s,5r,6e)-3,4,5-trihydroxy-n-[(3s)-2-hydroxy-4,5,6,7-tetrahydro-3h-azepin-3-yl]-2-methoxy-8-methylnon-6-enimidic acid

(2r,3r,4s,5r,6e)-3,4,5-trihydroxy-n-[(3s)-2-hydroxy-4,5,6,7-tetrahydro-3h-azepin-3-yl]-2-methoxy-8-methylnon-6-enimidic acid

C17H30N2O6 (358.2104)


   

methyl 2-(acetyloxy)-3a,7-dihydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylate

methyl 2-(acetyloxy)-3a,7-dihydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylate

C18H30O7 (358.1991)


   

8-hydroxy-6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

8-hydroxy-6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

[C21H28NO4]+ (358.2018)